Tumors Characterized By Genetic Abnormalities of Alk

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2014-08-11
Clinical Trial Update: A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase [Phase 1]
Phase 1 dose-escalation/expansion trial of LDK378 in ALK-altered tumors has completed with posted results.